The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have today announced a new liaison programme, marking a significant step forward in strengthening the regulatory partnership between the UK and the US. Speaking at the DIA Global Annual Meeting in Philadelphia, MHRA CEO Lawrence Tallon and FDA Deputy Commissioner Grace Graham announced the initiative to an audience […]